During the opening session of the AACR Conference on Drug Discovery and Development, the conference cochairs—Patricia M. LoRusso, DO,...
Currently, anti-EGFR therapies are approved by the U.S. Food and Drug Administration for the treatment of non-small cell lung...
Today, the American Association for Cancer Research (AACR), in conjunction with its Fellows of the AACR Academy, Rep. André...
In recognition of June as Cancer Immunotherapy Month, organized by our colleagues at the Cancer Research Institute (CRI), the...
Conference co-chair Elaine R. Mardis, PhD, discusses the third conference in the AACR's Precision Medicine Series, “Integrating Clinical Genomics...
AACR membership includes scientists and physicians from across the cancer research enterprise. Whether basic, translational, or clinical researchers, they...
Over 50 percent of all cancer patients will receive radiation therapy during the course of their treatments. This fact...
Guest Post by Carlos S. Moreno, PhD Winship Cancer Institute of Emory University
Over the years, clinical research has become an integral part of the American Association for Cancer Research’s meetings and...
May is Brain Cancer Awareness Month, and this week, the sharpest minds in brain cancer research will convene in...
We asked Eric Winer, MD, chief of the Division of Women's Cancers and director of the Breast Oncology Center...